Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · September 23, 2019

Response to Anti-EGFR Therapy in Patients With BRAF Non-V600–Mutant Metastatic Colorectal Cancer

Clinical Cancer Research

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Cancer Research
Response to Anti-EGFR Therapy in Patients With BRAF Non-V600–Mutant Metastatic Colorectal Cancer
Clin. Cancer Res 2019 Sep 12;[EPub Ahead of Print], R Yaeger, D Kotani, S Mondaca, AR Parikh, H Bando, EE Van Seventer, H Taniguchi, H Zhao, CN Thant, E de Stanchina, N Rosen, RB Corcoran, T Yoshino, Z Yao, H Ebi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading